Drs. Susumu Kobayashi and Alexandre Reuben Announced as Recipients of EGFR Resisters/LUNGevity Research Award

Researchers aim for innovative approaches to overcome drug resistance in patients living with EGFR-positive non-small cell lung cancer WASHINGTON, Nov. 1, 2023 /PRNewswire/ — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is thrilled to announce…